Caligan Partners将支持以每股至少3美元的价格出售该公司。潜在的购买方可能包括CSL Behring(OTCPK:CSLY)、Grifols(纳斯达克:GRFS)、武田夏尔和Octaharma。私募股权机构也可能对公司感兴趣。
查看全文
智通财经APP了解到,低价股虽然波动很大,但可能成为投资组合中有吸引力的补充部分。 尽管今年美股大幅下滑,但一些低价生物科技股实现了三位数涨幅。具体如下: ADMA Biologics 对ADMA Biologics(ADMA.US)来说,今年是丰收的一年,其股... 网页链接
$ADMA Biologics Inc(ADMA)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-06-04 AccNo: 0001193805-18-000788 Size: 24 KB 网页链接
$ADMA Biologics Inc(ADMA)$ EFFECT - Notice of Effectiveness Filed: 2018-05-31 AccNo: 9999999995-18-001396 Size: 1 KB 网页链接
$ADMA Biologics Inc(ADMA)$ S-3/A [Amend] - Registration statement under Securities Act of 1933 Filed: 2018-05-29 AccNo: 0001193805-18-000764 Size: 563 KB 网页链接
$ADMA Biologics Inc(ADMA)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2018-05-21 AccNo: 0001387131-18-002304 Size: 31 KB 网页链接
$ADMA Biologics Inc(ADMA)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2018-05-21 AccNo: 0001387131-18-002304 Size: 31 KB 网页链接
$ADMA Biologics Inc(ADMA)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2018-05-18 AccNo: 0001193805-18-000727 Size: 475 KB 网页链接
$ADMA Biologics Inc(ADMA)$ 8-K - Current report Filed: 2018-05-16 AccNo: 0001193805-18-000690 Size: 43 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$ADMA Biologics Inc(ADMA)$ 8-K - Current report Filed: 2018-05-16 AccNo: 0001193805-18-000690 Size: 43 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$ADMA Biologics Inc(ADMA)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-14 AccNo: 0001193805-18-000666 Size: 3 MB 网页链接
$ADMA Biologics Inc(ADMA)$ 8-K - Current report Filed: 2018-05-14 AccNo: 0001193805-18-000665 Size: 109 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接